Camlin Fine Sciences has received an order from the Additional Commissioner of CGST & Central Excise, confirming a GST demand of ₹6.43 crore along with an equal penalty for the period from July 2017 to March 2023. The company plans to challenge this order in higher courts, indicating a proactive approach to dispute resolution. Despite the significant financial figure involved, management states that there is no material impact on its financial performance or operations. This development could prompt cautious sentiment among investors, as ongoing legal proceedings might lead to uncertainty, but the company's readiness to contest the order may offer a positive outlook in the long run.